Partenaires

Logo Chimiothèque Nationale
CNRS

Plaquette de la CN

plaquette


Rechercher

Sur ce site


Sur le Web du CNRS




Certification ISO 9001:2015

iso


Accueil du site > Publications > 2- Criblages de chimiothèques > 2015

Publications 2015

1. Guillaume Kellermann, Markus Kaiser, Florent Dingli, Olivier Lahuna, Delphine Naud-Martin, Florence Mahuteau-Betzer, Damarys Loew, Evelyne Ségal-Bendirdjian, Marie-Paule Teulade-Fichou and Sophie Bombard
Identification of human telomerase assembly inhibitors enabled by a novel method to produce hTERT
Nucleic Acids Research, 2015 doi : 10.1093/nar/gkv425.

2. Kieffer, C. ; Cohen, A. ; Verhaeghe, P. ; Paloque, L. ; Hutter, S. ; Castera-Ducros, C. ; Laget, M. ; Rault, S. ; Valentin, A. ; Rathelot, P. ; Azas, N. ; Vanelle, P.
Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series
Bioorg. Med. Chem. 2015, 23, 2377-2386.

3. Kieffer, C. ; Cohen, A. ; Verhaeghe, P. ; Hutter, S. ; Castera-Ducros, C. ; Laget, M. ; Remusat, V. ; M’Rabet, M. ; Rault, S. ; Rathelot, P. ; Azas, N. ; Vanelle, P.
Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series
European Journal of Medicinal Chemistry 2015, 92, 282-294.

4. Cohen, A. ; Suzanne, P. ; Lancelot, J.-C. ; Verhaeghe, P. ; Lesnard, A. ; Basmaciyan, L. ; Hutter, S. ; Laget, M. ; Dumètre, A. ; Paloque, L. ; Deharo, E. ; Crozet, M. D. ; Rathelot, P. ; Dallemagne, P. ; Lorthiois, A. ; Sibley, C. H. ; Vanelle, P. ; Valentin, A. ; Mazier, D. ; Rault, S. ; Azas, N.
Discovery of New Thienopyrimidinone Derivatives Displaying Antimalarial Properties toward Both Erythrocytic and Hepatic Stages of Plasmodium
Eur. J. Med. Chem. 2015, 95, 16–28.

5. M. Zeniou, M. Fève, S. Mameri, J. Dong, C. Salomé, W. Chen, E.A. El-Habr, F. Bousson, M. Sy, J. Obszynski, A. Boh, P. Villa, S.Assad Kahn, B. Didier, D. Bagnard, M.P. Junier, H. Chneiweiss, J. Haiech, M. Hibert, M.C. Kilhoffer.
Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells
PLos One, 2015, 13, 10(8):e0134793.

6. A. Seguin, V. Monnier, A. Palandri, F. Bihel, M. Rera, M. Schmitt, JM. Camadro, H. Tricoire, E. Lesuisse.
A Yeast/Drosophila screen to identify new compounds overcoming frataxin deficiency
Oxidative Medicine and Cellular Longevity 2015, 565140.

7. I. Buffel, A. Meurs, J. Portelli, R. Raedt, V. De Herdt, L. Sioncke, W. Wadman, F. Bihel, M. Schmitt, K. Vonck, J.J. Bourguignon, F. Simonin, I. Smolders, P.Boon.
Neuropeptide FF and prolactin releasing peptide decrease cortical excitability through activation of NPFF receptors
Epilepsia 2015, 56, 489-498.

8. J. Portelli, A. Meurs, F. Bihel, H. Hammoud, M. Schmitt, J. De Kock, V. Utard, J.-P. Humbert, I. Bertin, I. Buffel, J. Coppens, D. Tourwe, V. Maes, A. De Prins, T. Vanhaecke, A. Massie, A. Balasubramaniam, P. Boon, J.J. Bourguignon, F. Simonin, I.Smolders.
Neuropeptide FF receptors as novel targets for limbic seizure attenuation
Neuropharmacology, 2015, 95, 415-423.

9. Lucas-Hourani, M., Munier-Lehmann, H., El Mazouni, F., Malmquist, N. A., Harpon, J., Coutant, E. P., Guillou, S., Helynck, O., Noel, A., Scherf, A., Phillips, M. A., Tangy, F., Vidalain, P. O. and Janin, Y. L.
Original 2-(3-Alkoxy-1H-pyrazol-1-yl)azines Inhibitors of Human Dihydroorotate Dehydrogenase (DHODH)
J. Med. Chem., 2015, 58, 5579-5598.

10. Munier-Lehmann, H., Lucas-Hourani, M., Guillou, S., Helynck, O., Zanghi, G., Noel, A., Tangy, F., Vidalain, P. O. and Janin, Y. L.
Original 2-(3-Alkoxy-1H-pyrazol-1-yl)pyrimidine Derivatives as Inhibitors of Human Dihydroorotate Dehydrogenase (DHODH)
J. Med. Chem., 2015, 58, 860-877.

11. D. Abboud, F. Daubeuf, Q.T. Do, V. Utard, P. Villa, J. Haiech, D. Bonnet, M. Hibert, P. Bernard, J-L. Galzi, N. Frossard
A strategy to discover decoy chemokine ligands with an anti-inflammatory activity
Sciencific Reports, 2015, 5, 14746.

12. Ly-Thuy-Tram Le, Morgane Couvet, Bertrand Favier, Jean-Luc Coll, Chi-Hung Nguyen, Annie Molla
Discovery of benzo[e]pyridoindolones as kinase inhibitors that disrupt mitosis exit while erasing AMPK-Thr172 phosphorylation on the spindle
Oncotarget. 2015 Sep 8 ; 6(26) : 22152–22166.

Mise à jour le 10 janvier 2017